Maina is a partner at Sofinnova Partners. She joined the firm in 2018 and has a long track record as a successful healthcare investor.
Prior to joining Sofinnova Partners, Maina was Director of Healthcare Investment at Touchstone Innovations (formerly Imperial Innovations) in London, UK, where she led and co-led investments in the UK.
Previously, she worked in the R&D teams of several UK and US biotech companies, including Celltech, Oxford Glyco Sciences, Chimeric Therapies and GeneMedicine.
Maina holds a B.S. from the University of Texas at Austin and an MBA from the Imperial Business School. Maina’s current investments include Sitryx Therapeutics, Cincor and Enyo Pharma.